Results 291 to 300 of about 1,093,427 (365)
Some of the next articles are maybe not open access.
Nature Reviews Disease Primers, 2019
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal tissue can also be damaged, leading to toxicity. Modern and precise radiotherapy techniques, such as intensity-modulated radiotherapy, may prevent toxicity, but some patients ...
D. de Ruysscher +5 more
semanticscholar +5 more sources
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal tissue can also be damaged, leading to toxicity. Modern and precise radiotherapy techniques, such as intensity-modulated radiotherapy, may prevent toxicity, but some patients ...
D. de Ruysscher +5 more
semanticscholar +5 more sources
Radiotherapy With or Without Chemotherapy in Muscle-Invasive Bladder Cancer
50 Studies Every Urologist Should Know, 2021This randomized study assessed the role of synchronous chemotherapy with intravenous 5-fluorouracil and mitomycin in patients with muscle-invasive bladder cancer undergoing radiotherapy compared to radiotherapy only.
V. Narayan
semanticscholar +1 more source
2011
Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved.
Sonja, Krause +2 more
openaire +2 more sources
Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved.
Sonja, Krause +2 more
openaire +2 more sources
The Lancet Respiratory Medicine, 2020
BACKGROUND Radiotherapy might augment systemic antitumoral responses to immunotherapy. In the PEMBRO-RT (phase 2) and MDACC (phase 1/2) trials, patients with metastatic non-small-cell lung cancer were randomly allocated immunotherapy (pembrolizumab) with
W. Theelen +19 more
semanticscholar +1 more source
BACKGROUND Radiotherapy might augment systemic antitumoral responses to immunotherapy. In the PEMBRO-RT (phase 2) and MDACC (phase 1/2) trials, patients with metastatic non-small-cell lung cancer were randomly allocated immunotherapy (pembrolizumab) with
W. Theelen +19 more
semanticscholar +1 more source
Radiotherapy, immunity, and immune checkpoint inhibitors.
The Lancet OncologyRadiotherapy exerts immunostimulatory and immunosuppressive effects, both locally, within the irradiated tumour microenvironment, and systemically, outside the radiation field.
C. Lynch, S. Pitroda, R. Weichselbaum
semanticscholar +1 more source
The Lancet, 2019
BACKGROUND Hypofractionated radiotherapy for prostate cancer has gained increased attention due to its proposed high radiation-fraction sensitivity.
A. Widmark +19 more
semanticscholar +1 more source
BACKGROUND Hypofractionated radiotherapy for prostate cancer has gained increased attention due to its proposed high radiation-fraction sensitivity.
A. Widmark +19 more
semanticscholar +1 more source
European Journal of Cancer, 1995
72 patients with either unresectable or pelvic recurrence of colorectal cancer were treated with combined radiotherapy and locoregional hyperthermia. Radiation doses were 50 Gy or more in patients not previously treated with radiotherapy, and 32 Gy (8 x 4 Gy) in patients who had previously received radiotherapy.
González González, D. +2 more
openaire +3 more sources
72 patients with either unresectable or pelvic recurrence of colorectal cancer were treated with combined radiotherapy and locoregional hyperthermia. Radiation doses were 50 Gy or more in patients not previously treated with radiotherapy, and 32 Gy (8 x 4 Gy) in patients who had previously received radiotherapy.
González González, D. +2 more
openaire +3 more sources
Hematology/Oncology Clinics of North America, 2005
Three to four thousand cases of malignant pleural mesothelioma will occur in the United States this year. Single-modality therapy with radiation plays a role for palliation. Radiation can prevent tumor recurrence at drain/instrumentation sites and provide symptomatic relief of pain and other complaints.
Craig W, Stevens +3 more
openaire +2 more sources
Three to four thousand cases of malignant pleural mesothelioma will occur in the United States this year. Single-modality therapy with radiation plays a role for palliation. Radiation can prevent tumor recurrence at drain/instrumentation sites and provide symptomatic relief of pain and other complaints.
Craig W, Stevens +3 more
openaire +2 more sources